Literature DB >> 6166631

Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin.

J R Stockigt, D J Topliss, J W Barlow, E L White, D M Hurley, P Taft.   

Abstract

Responses of the pituitary-thyroid axis and T4 binding to plasma proteins were studied in three kindreds with familial euthyroid T4 excess, an autosomal dominant condition in which affected subjects have high concentrations of plasma T4 with a high free T4 index, but normal free T4 by equilibrium dialysis. Treatment of affected subjects with exogenous T4 or T3 led to gradual suppression of TSH secretion when the free level of T4 or T3 increased above normal. When total T4 was reduced toward normal by potassium iodide treatment or previous subtotal thyroidectomy, the findings suggested mild hormone deficiency. In affected subjects from all three families, equilibrium dialysis showed increased [125I]T4 binding, with evidence of abnormal high capacity binding when an excess of unlabeled T4 was added. In contrast, T3 binding showed no major abnormality. Serum concentrations of T4-binding globulin, prealbumin, and albumin were normal, but gel electrophoresis and immunoprecipitation of binding proteins indicated that 25-30% of tracer [125I]T4 was albumin bound (normal, 10-12%). Abnormal binding, studied by an adsorption separation system in the presence of T4 excess, was inhibited by increments of barbitone. These findings suggest that T4 excess is an appropriate response to abnormal T4 binding so as to maintain normal free T4. The excess bound T4 is associated with a normal quantity of albumin. The basis for increased T4-albumin binding remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166631     DOI: 10.1210/jcem-53-2-353

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Iatrogenic hypothyroidism and postpartum hyperthyroidism in familial dysalbuminaemic hyperthyroxinaemia.

Authors:  A Jones; M R Hopton; K J Gurling; J S Harrop
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

2.  Familial dysalbuminaemic hyperthyroxinaemia.

Authors:  S J Fleming; G F Applegate; C G Beardwell
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

3.  Familial abnormalities of thyroxine binding proteins: some problems of recognition and interpretation.

Authors:  J E Neild; P G Byfield; M R Lalloz; D Tait; J H Marigold; D N Croft; B M Slavin
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

Review 4.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

5.  Hyperthyroxinemia associated with high thyroxine binding to albumin in euthyroid subjects.

Authors:  P De Nayer; P Malvaux
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

6.  Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin.

Authors:  R Bianchi; G Iervasi; A Pilo; F Vitek; M Ferdeghini; F Cazzuola; G Giraudi
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.

Authors:  P P Yeo; Y Yabu; J R Etzkorn; R Rajatanavin; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

8.  High serum thyroxine-binding globulin--an important cause of hyperthyroxinaemia.

Authors:  B C Leahy; D Davies; I Laing; L Walton
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

9.  Circulating thyroid hormones in progressive renal failure in the baboon (Papio ursinus).

Authors:  W J Kalk; M van Drimmelen; M Fitzpatrick; J A Myburgh; J A Smit; L van der Walt
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

10.  A new type of albumin with predominantly increased binding affinity for 3,3',5-triiodothyronine in a patient with Graves' disease.

Authors:  Y Yabu; K Miyai; A Kobayashi; K Miki; K Doi; J Takamatsu; T Mozai; F Matsuzuka; K Kuma
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.